Articles for author: Russ Cohen

Russ Cohen

Exploring the Potential of Ultra-High-Yield Dividend Stocks Exploring the Potential of Ultra-High-Yield Dividend Stocks

The Allure of Dividend Stocks Investing in dividend stocks has been a tried and true strategy for building wealth over the past 50 years. With companies sharing profits with investors, these stocks often stand the test of time, offering consistent returns compared to non-dividend payers. The Power of Dividends A study spanning from 1973 to ...

Russ Cohen

Insight into Mining Co’s Strategic Position in the Market Insight into Mining Co’s Strategic Position in the Market

There may never have been a better moment to navigate the complex terrain of the mining industry, especially for companies specializing in the extraction of copper, gold, and silver. In the midst of this deluge of opportunity stands the formidable Fitzroy Minerals Inc.FTZFF. An imminent copper deficit looms large on the horizon, poised to catapult ...

Russ Cohen

Top 3 Consumer Stocks That May Explode This Month

Unveiling the Potential Gems Among Consumer Stocks The Quest for Undervalued Consumer Stocks Opportunities in the stock market are akin to hidden treasures waiting to be discovered. The realm of consumer stocks, in particular, is buzzing with potential gems that may have been overlooked. As traders navigate the tumultuous seas of price action, the RSI ...

Russ Cohen

The Analysis of SM Energy: Navigating Broker Recommendations Strategically

Investors often lean on analyst recommendations to make stock decisions, but should these be gospel truth? Let’s delve into the numbers behind the brokerage recommendations for SM Energy (SM) and decipher how to wield this information wisely. Understanding Brokerage Recommendation Landscape for SM SM Energy currently boasts an average brokerage recommendation (ABR) of 1.79, painting ...

Russ Cohen

Analysis: UnitedHealth Group’s Resilient Rebound Signals a Healthy Buying Opportunity

Following the Q3 earnings release, UnitedHealth Group’s stock price experienced a setback akin to a temperamental child’s outburst. The results, however, were commendable, surpassing consensus estimates and buoyed by encouraging guidance. Despite market discontent triggering a sell-off, this stalwart of a company, with its robust growth and dividend payouts, maintains its value proposition for investors. ...

Russ Cohen

Alibaba’s Lazada Employs AI to Combat Competition in Southeast Asia Alibaba’s (BABA) Lazada Employs AI to Combat Competition in Southeast Asia

Alibaba’s e-commerce platform in Southeast Asia, Lazada, undertakes a substantial leap into generative AI to allure a diverse user base amidst escalating rivalry in Southeast Asia. Over the past two years, Alibaba has funneled approximately $2 billion into Lazada. The infusion arrives as Lazada grapples with upholding its market share in Southeast Asia, where Shopee ...

Russ Cohen

Taiwan Semiconductor: Powering the AI Revolution Taiwan Semiconductor: Powering the AI Revolution

Taiwan Semiconductor (TSM) reported quarterly earnings this morning and did not disappoint shareholders. Earnings came in 8.9% above analysts’ expectations and showed a 54.2% year-over-year (YoY) increase, while revenue beat estimates by 1.3% and grew an impressive 39% YoY. Management offered encouraging comments as well, with Wendell Huang, Senior VP and Chief Financial Officer saying, ...

Russ Cohen

Dominion & Amazon Collaboration to Develop SMRs in Virginia A Groundbreaking Collaboration: Dominion Energy and Amazon Explore SMR Development in Virginia

Dominion Energy recently signed a Memorandum of Understanding with Amazon.com to delve into cutting-edge development structures for enhancing Small Modular Reactor (“SMR”) nuclear development in Virginia. This strategic partnership aims to strengthen Dominion’s presence in the growing power demand market in Virginia by venturing into the uncharted territory of SMR technology. This collaboration is poised ...

Russ Cohen

Allarity Therapeutics, Inc. Securities Fraud Lawsuit: A Glimpse into Investor Opportunities

Legal Battle Unfolds LOS ANGELES, Oct. 17, 2024 /PRNewswire/ — Investors hit by significant losses are now offered a chance to spearhead the securities fraud class action lawsuit against Allarity Therapeutics, Inc. (“Allarity” or the “Company”) ALLR. Key Dates and Details Class Period: May 17, 2022 – July 19, 2024Lead Plaintiff Deadline: November 12, 2024 ...